(Q37982217)

26 August 2017

The nature, assessment, and treatment of obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

26 August 2017

0 references

5

Eric A Storch

1 reference

26 August 2017

4

Tanya K Murphy

1 reference

26 August 2017

Joseph F McGuire

1

1 reference

26 August 2017

Adam B Lewin

series ordinal

2

1 reference

26 August 2017

Betty Horng

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

26 August 2017

Postgraduate Medicine

1 reference

26 August 2017

124

1 reference

26 August 2017

1

1 reference

26 August 2017

152-165

1 reference

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

26 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Predictors of functional impairment in pediatric obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Multiple pathways to functional impairment in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Impact of obsessive-compulsive disorder on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Non-clinical obsessions in a young adolescent population: frequency and association with metacognitive variables

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Abnormal and normal obsessions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A naturalistic study of referred children and adolescents with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Florida Obsessive-Compulsive Inventory: development, reliability, and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Obsessive-compulsive symptoms: the contribution of obsessional beliefs and experiential avoidance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Meta-analysis of the symptom structure of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Brain-behavior relationships in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A meta-analysis of functional neuroimaging in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The neural bases of obsessive-compulsive disorder in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Functional neuroimaging in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Neuropsychology of obsessive-compulsive disorder: a review and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A family study of obsessive-compulsive disorder with pediatric probands.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A family study of early-onset obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Cognitive-behavioural factors and the persistence of intrusive thoughts in obsessional problems

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Disgust in contamination-based obsessive-compulsive disorder: a review and model

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Symptoms of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Not just right experiences and obsessive-compulsive features: experimental and self-monitoring perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Potentials and limitations of cognitive treatments for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Immunology of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Obsessive-compulsive disorder in children and adolescents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Obsessive-compulsive and spectrum disorders in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Functional impairment in children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Adaptive, emotional, and family functioning of children with obsessive-compulsive disorder and comorbid attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Functional impairment in clinical samples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Functional impairment in childhood OCD: development and psychometrics properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Anxiety and OC spectrum disorders over life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Autistic children as adults: psychiatric, social, and behavioral outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Autistic traits in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Correlates and mediators of functional disability in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Evidence-Based Assessment of Child Obsessive Compulsive Disorder: Recommendations for Clinical Practice and Treatment Research

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Clinical implications of insight assessment in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Correlates of insight among youth with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The Yale-Brown Obsessive Compulsive Scale. II. Validity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Refining clinical judgment of treatment outcome in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The Obsessive-Compulsive Inventory: development and validation of a short version

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Assessment of obsessive-compulsive disorder: review and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Development and validation of a child version of the obsessive compulsive inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Psychological treatment of obsessive-compulsive disorder: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

An open trial of intensive family based cognitive-behavioral therapy in youth with obsessive-compulsive disorder who are medication partial responders or nonresponders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

The efficacy of an internet-based cognitive-behavioral therapy intervention for child anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A review of pharmacologic treatments for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Risk of adverse behavioral effects with pediatric use of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

SSRI adverse events: how to monitor and manage

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Risks from antipsychotic medications in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Memantine as an augmenting agent for severe pediatric OCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Controlled trial of exposure and response prevention in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Quality of Life in Anxiety Disorders: A Comparison of Obsessive-Compulsive Disorder, Social Anxiety Disorder, and Panic Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.01.2528

21 January 2018

Identifiers

DOI

10.3810/PGM.2012.01.2528

1 reference

26 August 2017

1 reference